Builders Firstsource diskutieren
Builders Firstsource
WKN: A0ER15 / Symbol: BLDR / Name: Builders FrstSrc / Aktie / Hausbau & Baumaterial / Mid Cap /
154,00 €
-1,75 %
Builders FirstSource, Inc. (NYSE: BLDR) had its price target raised by analysts at Benchmark Co. from $95.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for BLDR provided by MarketBeat
Builders FirstSource, Inc. (NYSE: BLDR) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $90.00 to $97.00. They now have a "buy" rating on the stock.
Ratings data for BLDR provided by MarketBeat
Builders FirstSource, Inc. (NYSE: BLDR) was upgraded by analysts at Zelman & Associates from a "hold" rating to a "buy" rating.
Ratings data for BLDR provided by MarketBeat
Builders FirstSource, Inc. (NYSE: BLDR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $175.00 price target on the stock.
Ratings data for BLDR provided by MarketBeat
Builders FirstSource, Inc. (NYSE: BLDR) had its price target raised by analysts at Stephens from $130.00 to $175.00. They now have an "overweight" rating on the stock.
Ratings data for BLDR provided by MarketBeat
Builders FirstSource, Inc. (NYSE: BLDR) had its price target raised by analysts at Royal Bank of Canada from $162.00 to $188.00. They now have an "outperform" rating on the stock.
Ratings data for BLDR provided by MarketBeat
Builders FirstSource, Inc. (NYSE: BLDR) had its price target raised by analysts at Truist Financial Co. from $148.00 to $175.00. They now have a "buy" rating on the stock.
Ratings data for BLDR provided by MarketBeat
Builders FirstSource, Inc. (NYSE: BLDR) is now covered by analysts at Loop Capital. They set a "buy" rating on the stock.
Ratings data for BLDR provided by MarketBeat
Builders FirstSource, Inc. (NYSE: BLDR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for BLDR provided by MarketBeat
Builders FirstSource, Inc. (NYSE: BLDR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $175.00 price target on the stock.
Ratings data for BLDR provided by MarketBeat
Builders FirstSource, Inc. (NYSE: BLDR) had its price target raised by analysts at Barclays PLC from $175.00 to $195.00. They now have an "overweight" rating on the stock.
Ratings data for BLDR provided by MarketBeat
Builders FirstSource, Inc. (NYSE: BLDR) had its price target raised by analysts at Stifel Nicolaus from $184.00 to $200.00. They now have a "buy" rating on the stock.
Ratings data for BLDR provided by MarketBeat
Builders FirstSource, Inc. (NYSE: BLDR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for BLDR provided by MarketBeat
Builders FirstSource, Inc. (NYSE: BLDR) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $220.00 price target on the stock.
Ratings data for BLDR provided by MarketBeat
Builders FirstSource, Inc. (NYSE: BLDR) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $200.00 price target on the stock, up previously from $153.00.
Ratings data for BLDR provided by MarketBeat
Builders FirstSource, Inc. (NYSE: BLDR) had its price target raised by analysts at Wedbush from $175.00 to $225.00. They now have an "outperform" rating on the stock.
Ratings data for BLDR provided by MarketBeat
Builders FirstSource, Inc. (NYSE: BLDR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for BLDR provided by MarketBeat
Builders FirstSource, Inc. (NYSE: BLDR) had its price target raised by analysts at Oppenheimer Holdings Inc. from $220.00 to $242.00. They now have an "outperform" rating on the stock.
Ratings data for BLDR provided by MarketBeat
Builders FirstSource, Inc. (NYSE: BLDR) had its price target raised by analysts at Royal Bank of Canada from $186.00 to $211.00. They now have an "outperform" rating on the stock.
Ratings data for BLDR provided by MarketBeat
Builders FirstSource, Inc. (NYSE: BLDR) had its price target raised by analysts at Barclays PLC from $195.00 to $235.00. They now have an "overweight" rating on the stock.
Ratings data for BLDR provided by MarketBeat
Neueste Beiträge
HC_Wainwright in Arrowhead Pharmaceuticals Inc. diskutieren